EGFR and mucositis: EGFR–TKI is maintained for grades 1 and 2, and temporarily discontinued for grade 3, until the stomatitis/mucositis improves to grade 2, at which point it is resumed at 50% of the original dose and then increased if symptoms do not get worse.